|
Robert H. Keller,
MD, MS, FACP, AAHIVS
Education and Training:
1966 Bachelor of Arts in Biology Master of Science in Biology
Fordham University, Bronx, New York
1966 Bachelor of Arts in Biology Master of Science in Biology
Fordham University, Bronx, New York
1970 Doctor of Medicine (MD) with honors Temple University,
Philadelphia, Pennsylvania
1970-1974 Internship, Resident and Senior Resident University
of Rochester, Rochester, New York
1974-1976 Fellow and Senior Fellow Department of Immunology
Mayo Clinic, Rochester, Minnesota
1976 Master of Science in Immunology Mayo Graduate School
of Medicine Rochester, Minnesota
Professional and Faculty Positions:
2006 Founder, CSO and Director of Medicine KBK Institute
of Advanced Medicine Hollywood, Florida
2001 Founder, Chairman, CEO & CSO Phoenix BioSciences
which has developed a new first in class and first in man
viral-host interaction inhibitor for HIV / AIDS
1999 Founder, Chairmain,CEO and CSO Vitimmune, Inc Hollywood,
Florida
1998 Voluntary Adjunct Professor Miller School of Medicine,
University of Miami Miami, Florida
1996 Chairman and CEO Immune Balance Technologies Hollywood,
Florida
1994-2006 Director of Medicine & Research BIODORON Medical
Center Hollywood, Florida
1994-1995 Consultant in Immunology and Hematology Health
Professionals, Inc and Center for Special Immunology
1992-1995 Director Immune Reconstitution Program Center
for Special Immunology
1992-1995 Medical Director Center for Special Immunology
Miami Beach, Florida
1987-1996 President and Medical Director The Wilson Bode
Center Fort Lauderdale, Florida
1986-1987 Associate Director of Research and Development
Coulter Immunology Coulter Electronics, Inc., Hialeah, Florida
1982-1986 Medical Director Wilson Bode Center for Hematology
and Immunology Research Milwaukee, Wisconsin
1982-1986 Clinical Professor Department of Health Sciences
(Hematology, Immunology, Flow Cytometry) University of Wisconsin
Milwaukee, Wisconsin
1982-1986 Associate Professor Departments of Medicine and
Biophysics Medical College of Wisconsin Milwaukee, Wisconsin
1982-1986 Clinical Investigator and Staff Physician Zablocki
VAMC Milwaukee, Wisconsin
1980-1982 Director of Immunology Midwest Children's Cancer
Center (Immunology, Flow Cytometry, Transplantation) Chief
of Immunology Milwaukee Children's Hospital Milwaukee, Wisconsin
1980-1982 Associate Professor Department of Pediatrics (Hematology/Oncology,
Immunology) Medical College of Wisconsin Milwaukee, Wisconsin
1979-1982 Clinical Associate Professor Department of Health
Sciences (Hematology, Immunology, Flow Cytometry) University
of Wisconsin Milwaukee, Wisconsin
1978-1980 Research Associate and Staff Physician Research
Service Zablocki VAMC Milwaukee, Wisconsin
1977-1980 Assistant Professor Department of Medicine (Hematology/Oncology)
Medical College of Wisconsin Milwaukee, Wisconsin
1977 Consultant And Assistant Professor Department of Immunology
Mayo Medical School Dept. of Medicine University of Minnesota
1974-1977 Fellow and Senior Research Fellow in Immunology
Mayo Clinic Foundation Mayo Graduate School of Medicine
Rochester, Minnesota
Hospital Staff Appointments:
1976-1977 Mayo Clinic, Rochester, Minnesota
1977-1986 Zablocki VAMC, Milwaukee, Wisconsin
1977-1986 Milwaukee County Medical Complex, Milwaukee, Wisconsin
1992-1997 Mount Sinai Medical Center, Miami Beach, Florida
1992-1999 Cleveland Clinic Hospital, Fort Lauderdale, Florida
1992-1999 Miami Heart Institute, Miami Beach, Florida
1997-1999 Palmetto General Hospital, Hialeah, Florida
1997- 2005 South Shore Hospital, Miami Beach, Florida
1997- 2005 Memorial Medical Center, Hollywood, Florida
1992- Broward General Medical Center, Fort Lauderdale, Florida
1997- Hollywood Medical Center, Hollywood, Florida
Fellowships and Awards:
1967-1969 Health Professions Scholarship
Temple University School of Medicine
1974-1975 Mayo Foundation Research Fellowship
Mayo Graduate School of Medicine
1975-1978 National Arthritis Foundation Fellowship
1978-1981 VA Career Development Award, Research Associate
1983-1986 VA Career Development Award, Clinical Investigator
Grant Support during Academic Tenure
1978-1980 Alpha-fetoprotein Immunoregulation in a Model
of Murine Lymphoma Veterans Administration Research Principal
Investigator $210,000
1981-1986 Immunoregulatory Dysfunction in Non-Hodgkin's
Lymphoma NIH, NCI Principal Investigator $430,000
1982-1986 Immunologic Studies of Environmental Lung Disease
NIH (NIAID) Co-Principal Investigator $525,000
1983-1986 VA Career Development Award Clinical Investigator
$240,000
1984-1986 Clinical Applications of Laser Flow Cytometry
Principal Investigator NIH (RR Shared Equipment Program)
$105,609
1984-1987 Immunoregulatory Dysfunction Principal Investigator
VA $245,000
1985-1986 Monoclonal Antibodies in the Detection of Cervical
Carcinoma Co-Principal Investigator Hillman Foundation $85,000
1986-1987 Isoprinosine Modulation of the Immuno- Regulatory
Imbalances in AIDS and ARC Principal Investigator of FDA
IND Newport Foundation $125,000
1986-1987 Isoprinosine Modulation of the Immuno- Regulatory
Imbalances in AIDS and ARC Principal Investigator of FDA
IND Newport Foundation $125,000
Honors:
1970 Alpha Omega Alpha Temple University, School of Medicine
1970 Medical Degree with honors Temple University, School
of Medicine
1979 Superior Performance Award in Research Veterans Administration
1980 Fellow, American College of Physicians
1991 Who's Who in Science and Technology
1994 Who's Who in the World
1996 Who's Who in Medicine and Science
1998 HIV Medical Professional of the Year PWAC, Broward
County, Florida
1999 Humanitarian of the Year National Hemophilia Foundation
2001 2000 Outstanding Scientists of the 21st Century
2002 1000 Great Americans of the 21st Century
2003 America's Top Physicians in Internal Medicine, Immunology
and Hematology
2004 Elected to Board of Governors
Academy of HIV Medicine of the State of Florida:
2004 AMA Physicians Recognition Award
2005 Greatest Scholars of the Twenty First Century
2006 Health Professional of the Year Invited Lectureships:
1977 Second Fogarty International Conference on Neonatal
Liver Disease Baltimore, Maryland
1977 International Conference on the Diagnosis and Prevention
of Neural Tube Defects Los Angeles, California
1977 Second International Conference on Diagnostic Immunology
Henniker, New Hampshire
1979 Radio immunochemical Detection of Cancer Albuquerque,
New Mexico
1980 Visiting Professor of Hematology University of Mississippi
Jackson, Mississippi
1981 Visiting Professor of Hematology University of California
Irvine, California
1981 Third International Conference on Diagnostic Immunology,
Section Chair
1982 Visiting Professor of Pathology University of Texas
Medical Branch Galveston, Texas
1983 Visiting Professor of Medicine Wilfred Hall Air Force
Research Center Galveston, Texas
1984 Visiting Professor Max Plank Institute for Biochemie
Munich, Germany
2005 Visiting Professor of Immunology and Pharmacology Peking
Union Medical School (University of Beijing) Beijing, China
Editorial Boards:
1986-1990 Diagnostic Immunology
1984-1986 Journal of Leukocyte Biology
2005 Interventions in Aging
Reviewer:
1990-Present Journal of Immunology
2005 Interventions in Aging
Consultant ships:
Coulter Epics
Coulter Immunology
Corning Scientific
National Aeronautics and Space Administration (NASA)
Abbott HIV Advisory Board
Baxter Advisory Board for Hemophilia
Baxter Advisory Board for Hemophilia Inhibitor Patients
Consultant in Cancer Therapy, PRSS-J, Tokyo, 2005
Medical Advisory Council, American Federation of Hemophilia,
2002
Board of Director Appointments:
2006 Member American Academy of HIV Medicine
2006 Member Biosource Therapeutics
2001 Chairman, Phoenix Bioscience
1999 Chairman, VitImmune
1996 Chairman, IBT
Scientific Advisory Boards:
2006 Cytodyn Inc
2006 Acthelon Medical
2006 Bioscource Therapeutics
Certifications:
National Board of Medical Examiners, 1971 and 1990
American Board of Internal Medicine, 1974
American Academy of HIV Medicine, 2001
American Academy of Anti Aging Medicine 2006
Current Medical Licensure:
New York #112195
Wisconsin #19121
Florida #58991
Certification:
ACLS 1990
ATLS 1990
Professional Societies:
Alpha Omega Alpha
American Association for the Advancement of Science
American Association of Immunologists
American College of Physicians
American Federation of Clinical Research
American Society of Clinical Pathology
American Society of Hematology
International Society of Hematology
International Society of Hematopathology
International Immunocompromised Host Society
International Society of Analytical Cytology
Clinical Cytometry Society
New York Academy of Sciences
Clinical Immunology Society
National Organization for Rare Disorders
American Academy of Anti Aginig Medicine
Teaching Experience:
1978-1980 Survey in Basic and Clinical Immunology Department
of Medicine Medical College of Wisconsin
1980-1983 Principles of Laser Flow Cytometry Department
of Health Sciences University of Wisconsin
1981 Special Topics in Immunology Immunoregulation in Cancer
Department of Biology Marquette University
1983-1986 Co-Director Flow Cytometry Program University
of Wisconsin Introduction to Flow Cytometric Analysis Principles
of Image and Laser Cytometry Hybridomas and Monoclonal Antibodies
Laboratory Evaluation of Immunoregulation Clinical Immunophenotyping
and DNA Analysis Advanced Cytometry Advanced Cytometric
Techniques
Invited Professional Lectures:
1979 - Dr. Keller has been the invited speaker at more than
2500 state, regional, National, and international, medical
and scientific seminars and workshops In the fields of:
AIDS and Immunoregulation
Clinical Immunology
Chronic Fatigue Syndrome and Fibromyalgia
Autoimmune Disease and Control of Aberrant Immune Response
Nutrition and the Immune Response
Hormones and the Immune Response
Hepatitis C
Hemophilia
Protecting the Immune System Before, During, and After Cancer
Therapy.
Age Management
2000-2002 Host of Today's Health, WAXY 790
and Web streamed at Vitimmune.com and RobKellermd.org
2005-2006 Host of Voice America Web Based Interactive Radio
Show, The Path to Wellness and Youth
Committee Service:
1985-1986 Veterans Administration Development Research and
Committee Clement J. Zablocki VAMC
1986-1989 VA Oncology Merit Review Board
1984-1986 International Society For Analytical Cytology:
Research and Development
1983-1986 Controls & Standards University of Wisconsin:
Co Chair Flow Cytometry
1983-1986 National Institutes of Health: Special Immunology
Review Council Study Section
1980-1982 Medical College of Wisconsin Faculty Welfare Committee
1980-1982 Animal Care Committee
1982-1986 Flow Cytometry Protocol Committee
1992 Cancer Committee for Hollywood Medical Center
1998 Committee of Ten Thousand Medical Advisory Board
1996 National Hemophilia Federation: Medical Advisory Committee
1994 National Hemophilia Foundation- Florida Chapter Medical
Advisory Committee
1994-1997 Mount Sinal Medical Center Cancer Committee
2001 Hollywood Medical Center Cancer Committee
2005 Underwriting Committee ProAssurance Malpractice
2005 AAHIVM Standards of Practice Committee
Statement of Research Interest:
HIV: Dissection of the immune perturbations
Associated with HIV infection including therapy with experimental
immunomodulary agents.
Dissection of the immune perturbations
Associated with hemophiliac complication and therapeutic
intervention using experimental immunoregulatory agents.
Creation and utilization of unique `designer`
monoclonal antibodies for the diagnosis, monitoring, imaging
and therapy of human hematologic and solid tumor malignancies.
Immune response and immunoregulation:
dissection of the basic human immune response and the roles
of cytokines and other regulatory molecules and the demonstration
and characterization of aberrant responses in neoplastic
and immunologic disease.
Nutritional/ Hormonal Supplementation
in Age Management and Immunologic Disease
Patents Issued:
R.H. Keller and Dr. X. Wen: Allerg-ease (Patent Number 6,180,106)
(2000)
R.H. Keller, D.W. Kirchenbaum: ALL-Immune (Patent Number
6,262,019) (2002)
R.H. Keller, PBS 119 a novel treatment for chronic viral
infections (Patent Number 6,734,192) (2004)
Patents Pending:
Keller R.H. A novel treatment For Viral Infections (CIP)
2005
Keller RH: An improved method for glutathione production
in mammals 2007
Keller RH: A nutritional formula to promote weight loss
in mammals
Keller RH: A novel treatment for neurodegenerative diseases
Keller RH: A nutritional formula to improve short term memory
function
Books:
Keller, R.H. After Thirty, Some Maintenance Is Required-A
Practical Guide to Age Management
Book Chapters:
Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein:
A Potential Regulator of Immune Function. In Diseases of
the Liver and Biliary Tract. Javitts, N.NIH, Bethesda, Maryland,
pp. 119-134, 1977.
Keller, R.H., Calvinico, N.J., Fink, J.N.,
and Stevens, J.O.: Immunobiologic Aspects of Primate Hypersensitivity
Pneumonitis. In Environmental Toxicology. Dungworth, D.L.
(Ed), Academic Press, New York, pp.383-395, 1981.
Keller, R.H., Blake, D.G., Lyman, S. and
Siebenlist, R.: The Immunobiology of Human Non-Hodgkin's'
Lymphomas. In Clinical Cellular Immunology. Ludered, A.
(ed). Humana Press, New York, pp. 213-246, 1982.
Patrick, C.W., Keller, R.H., and Horan,
P.K.: Flow Cytometry, Cell Sorting and Hybridomas. American
Society Clinical Pathology Press. St. Louis, MO, pp. 1-182,
1982.
Patrick, C.W., Parker, J., Keller, R.H.,
and Horan, P.K.: The Clinical Utility of Monoclonal Antibodies
and Immunophenotyping. In Flow Cytometry and Cell Sorting
in Hematologic Disease. American Society of American Pathologists
Press. Chicago, IL pp. 1-191.
Calvinico, N.J., Fink, J.N., and Keller,
R.H.: Hypersensitivity Pneumonitis. In The Immunology of
the Lung. Bienenstock, J. (Ed), Academic Press, New York
pp 365-366, 1984
Keller, R.H., Milson, T.J., Janicek, K.M.,
Patrick, L.C., Sohnle, P., and Patrick, C.W.: Clinical Utilization
of the Technicon H-6000 Flow Cytochemical Flow System in
Allergy Testing. In Proceedings of the 4th International
Technicon Hematology Colloquium. Simson, E. (ed) Academic
Press, New York, pp 179- 188, 1984.
Patrick, C.W., Horan, P.K, and Keller,
R.H.: Immunophenotypic and Functional Analysis Using Laser
Flow Cytometry: Clinical Utility. American Society of Clinical
Pathology Press, Chicago, IL, 1985, pp. 1-168.
Patrick, C.W. and Keller, R.H.: Lymphocytes:
Biochemistry, Physiology, Function and Morphology. In Principles
of Hematology: Clinical and Laboratory Practice. R.L. Bick,
(Ed) C.V. Mosby, St. Louis, MO in press.
Patrick, C.W. and Keller, R.H.: The Emerging
Role of Laser Flow Cytometry and Monoclonal Antibodies in
Clinical Medicine. In: Principles of Hematology: Clinical
Laboratory Practice. R.L. Bick (Ed) C.V. Mosby, St. Louis,
MO, in press.
Keller, R.H. and Patrick, C.W.: Characterization
of the Human Myeloid Series by Monoclonal Antibodies. In
Monoclonal Antibodies in Laboratory Medicine. Swartz, M.
(Ed) Academic Press, New York, in press.
Patrick, C.W., McFadden, P.W., and Keller,
R.H.: Immunophenotypic Analysis of Human Bone Marrow Employing
Monoclonal Antibodies and Laser Flow Cytometry. In Proceedings
of the Second International Conference on Technological
Advances in Laboratory Hematology. Howen, B. (ed),Academic
Press, 1985.
Keller, R.H., Janicek, K.M., and Patrick,
C.W.: The Clinical Significance of Laser Flow Cytometry
DNA Analysis. In Proceedings of the Second International
Conference on Technological Advances in Laboratory Hematology.
Howen, B. (Ed) Academic Press, New York, 1985.
Keller, R.H., Van Riel, F., Maislis, J.,
Lane, J.T., Reiter, W.M., Klimas, N.G, Fletcher, M.A.: Association
of Histocompatability Class II Antigens wit the Chronic
Fatigue Immune Dysfunction Syndrome. In Clinical Infectious
Disease. University of Chicago, Chicago, IL, 1994:18 (Supp
1): S154-6.
Antioxidants and the skin, A Paradigm
for aging. Keller, R.H and E Arrayove (in press) 2004. glutathione
in Aging and Immunologic Disease. Loss of Gastrointestinal
During Aging and Immunologic Disease Both Ed R. Wallace
and Mechanisms of Aging Dove Press N Z, 2006
Original Research Contributions and Invited
Reviews: Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein,
E-Rosette Formation and Tumor Cell Growth. N Engl J Med
293(24): 1265-1266, 1975.
Tomasi, T.B., Dattwyler, R., Murgita,
R. and Keller, R.H.: Immunosuppression By Alpha-fetoprotein.
Trans Am Assoc Phys. 88:293-298, 1976.
Geubel, A.P., Keller, R.H., Summerkill,
W.H.J., Dickson, E.R., Tomasi, T.B. and Shorter, R.G.: Lymphocyte
Cytotoxicity and Inhibition Studied with Autologous Liver
Cells: Observation in Chronic Acute Liver Disease and the
Primary Biliary Cirrhosis Syndrome. Gasterenterol. 71:450-459,
1976.
Keller, R.H. and Clavanico, N.J., and
Tomasi, T.B.: Immunosuppressive Properties of AFP: Role
of Estrogens. In Onco Developmental Gene Expression. Fichman,
W.H. and Sell, S. (eds) Academic Press, New York, p.278,
1976.
Keller, R.H. and Tomasi, T.B.: Synthesis
of Alpha-fetoprotein by Murine Lymphoid Cells in Allogenic
Reactions. J Exp Med 143:1120, 1976.
Banks, P., Keller, R.H., Li, V.Y. and
White, E.B.: Malignant Lymphomas of Plasmablastic Identity:
A Neoplasm with Both "Immunoblastic" and Plasma
Cell Features. Am J Med 64:609-610, 1978.
Keller, R.H., Atwater, J.S., Martin, R.S.
and Tomasi, T.B.: Ataxia Telangiectasia, Immunosuppression
and AFP: Is There a Relationship? In Prevention of Neural-
Tube Defects. Crandall, B. (ed) Academic Press, New York,
pp.27-40, 1978.
Guirgis, H.A., Lynch, H.T., Keller, R.H.,
Tomasi, T.B., Vandervoorde, J., Brodky, F., Lynch, J., Rankin,
L. and Malony, K.: Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein
(AFP) in Cancer-Prone Families: Communicable Implications.
In Proceeding of the Third Annual Symposium on the Detection
and Prevention of Cancer. Part I (2), 1987.
Keller, R.H., Dattwyler, R.J., Harrison,
E. and Tomasi, T.B.: Alpha-fetoprotein in Human Lymphoproliferative
Disease. J Lab Clin Immunol, 2:93-98, 1979.
Kaplan, H.J., Meredith, T.A., Aeberg,
T.M. and Keller, R.H.: Intraocular Reticulum Cell Sarcoma
(Histiocytic Lymphoma) in Richter's Syndrome: A Neoplasm
of the Immune System. Arch Opthal 98:707-710, 1980.
Keller, R.H., Blake, B.G., Lyman, S. and
Siebenlist, R.: ImmunoregulatoryAbnormalities in Chronic
Lymphocytic Leukemia. J Lab Clin Immunol 6:201-208, 1981.
Choi, H. and Keller, R.H.: Co-existence
of Chronic Lymphocytic Leukemia and Hodgkin's Disease. Cancer
48:48-55, 1981.
Kaplan, H.J., Aeberg, T.M. and Keller,
R.H.: Etiology of Recurrent Clinical Uveitis. Ber Dtsch
Ophthal Ges 78:159, 1981.
Kaplan, H.J. and Keller, R.H.: Recurrent
Clinical Uveitis: Cell Surface Markers on Vitreous Lymphocytes.
Arch Ophthal 100:585-592, 1982
Keller, R.H., Fink, J.N., Lyman, S. and
Pederson, G.: Suppressor Cells in Asymptomatic Pigeon Breeders.
J Clin Immunol 2:46-51, 1982.
Milson, T.J., Grief, D. and Keller, R.H.:
The Variable Effect of Cryopreservation on Peripheral Blood
Mononuclear Populations. J Clin Lab Immunol 7:205-218, 1982.
Keller, R.H., Calvanico, N.J. and Stevens,
J.O.: Hypersensitivity Pneumonitis In Non-human Primates.
In Studies on the Relationship of Immunoregulation and Disease
Activity. J Immunol 128:116-123, 1982.
Keller, R.H.: Alpha-fetoprotein: Biologic
and Clinical Potential. In Tumor Imaging: The Radioimmunochemical
Detection of Cancer. Burchiel, S. and Rhodes, B. (eds) Mason
Publishing, New York, pp. 179-188, 1982.
Patrick, C.W. and Keller, R.H.: New Techniques
in the Diagnosis of Hematopoietic Malignancies: Monoclonal
Antibodies, Flow Cytometry and Cell Sorting. Am Soc Clin
Pathol Sp Topic Series 20(3)106-109, 1982.
Keller, R.H., Libnoch, J.A., Patrick,
C.W., Blake, D.G., Choi, H. and Hanson, R.D.: Fc Gamma Bearing
T Cells in Non-Hodgkin's Lymphomas. Diag Immunol 1:27-32,
1983.
Keller, R.H., Feldman, E. and Libnoch,
J.A.: Immunoregulatory Abnormalities the Kindred of Waldenstrum's
Macroglobulinemia Patients. Am J Hematol 14:15-22, 1983.
Keller, R.H. and Calvanico, N.J.: Suppressor
Macro-molecules. Crit Rev Immunol 5(2): 149-199, 1984.
Fudenberg, H.H., Wilson, G.B., Keller,
R.H., Metcalf, J.F., Pauling, E.E., Stuart, E.J. and Floyd,
E.: Clinical Application of the Leukocyte Migration Inhibition
Assay: New Methods for Determining Transfer Factor Potency
and for Prediction of Clinical Response. In Proceedings
of the IV International Conference on Transfer Factor. Academic
Press, New York, pp. 293-310, 1984.
Patrick, C.W. and Keller, R.H.: A Simple
Device for the Collection of Cells Sorted by Flow Cytometry:
Preservation of Integrity and Viability. Cytometry 5(3):308-311,
1984.
Keller, R.H., Milson, T.J., Janicek, K.M.
and Patrick, C.W.: Monoclonal Antibodies: Clinical Utility
and the Misunderstood Epitope. Lab Med 15(12):785-802, 1984.
Keller, R.H., Swartz, S.J., Leven, S.,
Bar Sella, S. and Fink, J.N.: Immunoregulation in Hypersensitivity
Pneumonitis: Phenotypic and Functional Studies of Bronchoalveolar
Lavage Lymphocytes. Am Rev Resp Dis 130:766- 771, 1984.
Patrick, C.W., Swartz, S.J., Harrison,
K.A. and Keller, R.H.: Collection and Preparation of Hemopoietic
Cells for Cell Marker Analysis. Lab Med 15(10): 659-665,
1984.
Patrick, C.W., Milson, T.J., McFadden,
P.W. and Keller, R.H.: Flow Cytometry and Cell Sorting.
Lab Med 15(11):740-745, 1984.
Wilson, G.B., Fudenberg, H.H. and Keller,
R.H.: Guidelines for Immunotherapy of Antigen Specific Defects
with Transfer Factor. J Clin Lab Immunol 13:51-58, 1984.
Baumann, M.A., Libnoch, J.A., Patrick,
C.W., Choi, H. and Keller, R.H.: Prolonged Survival in Richter's
Syndrome with Subsequent Re-emergence of Chronic Lymphocytic
Leukemia: A Case Report Including Serial Cell Surface Phenotype
Analysis. Am J Hematol 20:67-72, 1985.
Marti, G.E., Patrick, C.W., Muirhead,
K., Magruder, L., Vail, M., Schuette, W., Keller, R.H.,
Horan, P.K. and Gralnick, H.R.: Normal Blood Density Gradient
Lymphocyte Subset Analysis: In an Inter-Laboratory Flow
Cytometric Comparison of 85 Normal Adults. Am J Hematol
20:41-52, 1985.
Milson, T.J., Patrick, C.W., Sohnle, P.G.,
Patrick, L.C. and Keller, R.H.: Flow Cytochemical Analysis
of Atopic Reactions. Diag Immunol 3:182-186, 1986.
Milson, T.J., Patrick, C.W., Torke, N.J.
and Keller, R.H.: Holding Media for Cell Surface Phenotyping
Analysis, J Immunol Methods 87: 155-159, 186.
Baumann, M.A., Milson, T.J., Patrick,
C.W., Libnoch, J.A. and Keller, R.H.: Immunoregulatory Abnormalities
in Myelodysplastic Disorders. Am K Hematol 22:79-86, 1986
Hansen, R.M, Lerner, N., Abrams, R.A.,
Patrick, C.W., Malik, M.I. and Keller, R.H.: Chronic Lymphocytic
Leukemia with Pure Red Cell Aplasia: Laboratory Demonstration
of Persistent Leukemia in Spite of Apparent Complete Clinical
Remission. Am J Hematol 22:79-86, 1986.
Baumann, M.A., Keller, McFadden, P.W.,
Libnoch, J.A and Patrick, C.W.: Myeloid Cell Surface Phenotype
in Myelodysplasia: Evidence for Abnormal Persistence of
an Early Myeloid Differentiation Antigen. Am J Hematol 23:22-26,
1986.
Baumann, M.A., Milson, T.J., Patrick,
C.W., Libnoch, J.A. and Keller, R.H.: Correlation of Numbers
of Natural Killer Cells with Clinical Course in Large Cell
Lymphoma. Cancer 57:2309-2312, 1986.
Patrick, C.W., Ash, R., Libnoch, J.A.
and Keller, R.H.: Clinical Cytometry and Immunophenotyping:
I. Flow Cytometric Analysis of Normal Peripheral Blood and
Bone Marrow. Path Immunopathol Res 6:64-76, 1987.
Patrick, C.W., Libnoch, J.A., Kallas,
G.A. and Keller, R.H.: Sequential Immunophenotypic Studies
in Chronic Lymphocytic Leukemia: UCLA Molecular Biology
Symposium. Chronic Lymphocytic Leukemia: Recent Progress-Future
Directions. R. Gale and K. Rai (eds) Alan R. Liss, New York,
59, 1987.
Keller, R.H., Libnoch, J.A., Kallas, G.A.,
and Patrick, C.W.: Sequential Evaluation of T Cell Subsets
in B-CLL. UCLA Molecular Biology Symposium Chronic Lymphocytic
Leukemia: Recent Progress-Future Directions. R. Galeand
K. Rai (eds) Alan R. Liss, New York, 59, 1987.
Fudenberg, H.H, Whitten, H.D., Galbraith,
G.M.P., Goust, J.M., Patrick, C.W. and Keller, R.H.: Deficiency
of 'Interactive' T Cells in Individuals with Recurrent Infection:
Effect of DLE-TF Therapy. Am J Med. In Press, 1994.
Keller, R.H., Van Reil, F., Maislis, J.,
Lane, J.T., Reiter, W.M., Klimas, N.G. and Fletcher, M.A.:
Association of Histocompatability Class II Antigens with
the Chronic Fatigue Immune Dysfunction Syndrome. In Clin
Inf Disease 1 8(Supp 1): S154-156, 1994.
Papers Submitted, In review and/or Revision
Patrick, C.W. and Keller, R.H.: A Comparative
Study of Anticoagulants in Cell Surface Maker Phenotyping
and Functional Analysis. Am J Clin Pathol.
Keller, R.H., Choi, H., Libnoch, J.A.
and Patrick, C.W.: A Natural Murine Model of Non-Hodgkin's
Lymphoma. J Immunol (in revision).
Choi, H., Libnoch, J.A., Aimargo, U.,
Heckman, M. and Keller, R.H.: Castelman's Tumor: Well Differentiated
Lymphocytic Lymphoma and Large Cell Lymphoma in a Single
Patient. Human Pathol (in revision).
Keller R.H., Wen K., and Kirchenbaum G.
ALL-ergese a TCM blend of standardized herbs for the treatment
of allergies. (in revision)
Adult Growth Hormone Deficiency: A Correlate
of Immune Overactivity (in preparation)
ABSTRACTS: Asterisks (*) denote those
papers selected for presentation at national or international
meetings.
* Keller, R.H., Dattwyler, R.J., Harrison,
E. and Tomasi, T.B.: Alpha- fetoprotein in Human Lymphoproliferative
Disease. Blood 46(4):1035, 1975.
* Guebel, A.P., Keller, R.H., Summerskill,
W.H.J., Tomasi, T.B. and Shorter, R.G.: Cytotoxicity of
Autologous and Normal Lymphocytes Against Isolated Liver
Cells in Patients with Primary Biliary Cirrhosis. Gastroenterol
68:104, 1975.
* Keller, R.H., Summerskill, W.H.J., Guebel,
A.P., Shorter, R.G., and Tomasi, T.B.: Alpha-fetoprotein
and Suppression of Cell Mediated Immunity in Chronic Acute
Liver Disease (CALD). Gastroenterol 70:A-43:901, 1976.
* Keller, R.H, Guirgis, H., Lynch, H.
and Tomasi, T.B.: Alpha-fetoprotein (AFP) in Cancer Prone
Families. Clin Res 24:331, 1976.
* Keller, R.H., Burritt, M.F., Thompson,
R.L. and Tomasi, T.B.: Alpha- fetoprotein (AFP): Synthesis
in Allogeneic Reactions. Clin Res 24:447, 1976.
* Keller, R.H., Burritt, M.F. and Tomasi,
T.B.: Alpha-fetoprotein (AFP) Synthesis in Allogeneic Reactions.
Eleventh Leukocyte Culture Conference, Tucson, AZ, September
1976.
* Guirgis, H.A., Lynch, H.T., Keller,
R.H., Tomasi, T.B., Vandervoorde, J., Lynch, J., Rankin,
L., Maoney, K. and Harris, R.: Carcinoembryonic Antigen
(CEA) and Alpha-fetoprotein (AFP) in Cancer Prone Families.
In Proceedings of the Scientific Session of the Third International
Symposium on the Detection and Prevention, 1976.
* Vogten, A.J.M., Shorter, R.G., Summerskill,
W.M.J., Keller, R.H. and Tomasi, T.B.: Cell Mediated Cytotoxicity
Against Human Liver Lipoprotein in Liver Disease. Gastroenterol
71:A-41:934, 1976.
* Keller, R.H. and Tomasi, T.B.: AFP:
A Potential Regulator of Immune Function. Second International
Conference on Disease of the Liver. Bethesda, MA, March
1977.
Keller, R.H., Blake, D.G., Lyman, S.,
Libnoch, J.A. and Fabiance, M.: Suppressor Cells in Asymptomatic
Chronic Lymphocytic Leukemia. Clin Res 27:298, 1979.
Keller, R.H., Blake, D.G., Lyman, S. and
Siebenlist, R.: Altered Immunoregulation in Chronic Lymphocytic
Leukemia. Blood 54:97A, 1979.
Blake, D.G., Libnoch, J.A., Lyman, S.
and Keller, R.H.: Altered Immunologic Reactivity in Myelodysplastic
Disorders. Blood, 54:97A, 1979.
* Miller, P.P, Jordan, R.E. and Keller,
R.H.: Suppression of Human Lymphocyte Response by Circulating
Immune Complexes. Clin Res 28: 351, 1980.
* Keller, R.H., Fink, N.J., Lyman, S.
and Pederson, G.: Altered Immunoregulation in Hypersensitivity
Pneumonitis. Clin Res 28:102, 1980.
* Keller, R.H., Lyman, S. and Siebenlist,
R.: The Influence of Human Mononuclear Cell Histamine Production
on T Cell Immunoregulation. Clin Res 28:230, 1980.
* Keller, R.H., Lyman, S. and Siebenlist,
R.: Histamine in the Immune Response. 4th World Congress
of Immunology, Paris, France. July 1980.
* Kaplan, H.J., Asberg, T.M. and Keller,
R.H.: Lymphocyte Subset in Clinical Uveitis. Abs Assoc Res
Vision Opthal p. 33, 1980.
* Siebenlist, R., Calvanico, N.J., Stevens,
J.O. and Keller, R.H.: Immunoregulation in Hypersensitivity
Pneumonitis. Fourth Midwest Autumn Immunology Conference,
Chicago, IL, 1980.
* Lyman, S., Patrick, C.W. and Keller,
R.H.: Non-Hodgkin's Lymphoma in the Mouse: A Naturally Occurring
Murine Model of NHL. Fourth Midwest Autumn Immunology Conference,
Chicago, IL, 1980.
* Young, D.G., Hussey, C.V., Keller, R.H.
and Pisciotta, A.V.: Eradication of Acquired Factor VII
Inhibitor in Hodgkin's Disease Following Chemotherapy. Am
Fed Clin Res 28(4):731, 1980.
* Keller, R.H., Patrick, C.W., Swartz,
S.J., Libnoch, J.A. and Jordan, R.E.: FlowCytometry as an
Adjunct in the Diagnosis and Staging of Lymphoproliferative
Disease. IX International Conference on Analytical Cytology.
Schloss Elmau, Germany, 1980.
* Wilson, R.J., Greiff, D. and Keller,
R.H.: Cryopreservation of Non- specific T Cell Suppressor
Cells. Cryobiol 17:597, 1980.
* Pontzer, C. and Keller, R.H.: Rabbit
Peripheral Blood T Cell Separation. Fed Am Soc Exp Biol,
1980.
* Keller, R.H., Calvanico, N.J. and Stevens,
J.O.: Immunoregulation in Pigeon Breeders Disease. Clin
Res 29:370, 1981.
* Keller, R.H., Kirchner, P., Lyman, S.,
Siebenlist, R., Choi, H. and Patrick, C.W.: Immunoregulatory
T Cells in Non-Hodgkin's Lymphomas. Blood 58:313, 1981.
* Keller, R.H., Lyman, S., Choi, H. and
Patrick, C.W.: A Natural Model of Non-Hodgkin's Lymphoma.
Blood 58:524, 1981.
* Lauer, S., Casper, J., Keller, R.H.,
Kirchner, P. and Camitta, B.: The Use of Counterflow Centrifugation-Elutriation
for the Separation of Bone Marrow Lymphoid Cells in Children
with Acute Lymphocytic Leukemia (ALL) and Metastatic Solid
Tumors. Blood 58:133, 1981.
* Keller, R.H., Choi, H. and Patrick,
C.W.: Nodular Non-Hodgkin's Lymphoma in the Mouse. Blood
60:114A, 1982.
* Keller, R.H., Lyons, M., Troy, J. and
Jordan, R.E.: Peripheral Blood Aneuploidy in Mycosis Fungoides
and Pre-mycotic Lesions. Blood 60:146A, 1982.
* Keller, R.H., Swartz, S.J., Lyons, M.,
Troy, J. and Jordan, R.E.: Peripheral Blood Involvement
in Skin-limited T Cell Malignancy. Am Fed Clin Res 31:568,
1983.
* Geoghegan, W.D., Jordan, R.E. and Keller,
R.H.: Non-Langerhans Cells in the Keratinocyte Band in Culture
Expressing HLA-DR. Invest Derm Am Fed Clin Res 31:568, 1983.
* Keller, R.H., Swartz, S.J., Patrick,
C.W. and Kaplan, H.J.: Intraocular Lymphoma: A Possible
Systemic Disease. Am Fed Clin Res 31:315, 1983.
* Patrick, C.W., Libnoch, J.A., Choi,
H. and Keller, R.H.: Flow Cytometric Peripheral Blood Cell
Surface Analysis as a Predictor of Richter's Syndrome (RS)
in Chronic Lymphocytic Leukemia. Blood 62:756, 1983.
* Patrick, C.W., Swartz, S.J. and Keller,
R.H.: A Comparative Study of Heparin and Potassium EDTA
as Anticoagulants for Cell Surface Marker and Immunologic
Functional Analysis. Am J Clin Pathol, 1983.
* Keller, R.H., Swartz, S.J., Patrick,
C.W., Steven, G. and Torke, N.J.: Regression of Natural
Murine Non-Hodgkin's Lymphoma Following Immunotherapy with
Immunoregulatory Cell Types. Blood 62:756, 1983.
* Keller, R.H., Wagner, D. and Patrick,
C.W.: Sequential T Cell Phenotypic and Functional Changes
During a Comparative Study of Rhinovirus Infection in Patients
with the Acquired Immune Deficiency Syndrome (AIDS). Blood
62:352, 1983.
* Keller, R.H., Swartz, S.J. and Patrick,
C.W.: Metachromatic Granules in Human T8 (CD8) Bearing Lymphocytes.
Fifth World Congress of Immunology. Tokyo, Japan. July 1983.
Libnoch, J.A., Patrick, C.W., Griffin,
J. and Keller, R.H.: Flow Cytometric Cell Surface Analysis
as a Predictor of Leukemic Transformation in the Myeo-dyplastic
Syndrome (MDS). Blood 62:610A, 1983.
* Calvanico, N.J., Pontzer, C. and Keller,
R.H.: Regulation of Aerosol Induced Pulmonary Inflammation
in Rabbits. XII Congress of the European Academy of Allergy
and Clinical Immunology, Rome, Italy, 1983.
* Patrick, C.W., Swartz, S.J., McFadden,
P.W., Wallace, A. and Keller, R.H.: A Comparative Study
of Manual and Flow Cytometry Cell Surface Marker Analysis.
Soc Analytical Cytology, Sea Island, Georgia, 1983.
* Keller, R.H., Swartz, S.J., Troy, J.,
Patrick, C.W. and Jordan, R.E.: Peripheral Blood Involvement
in Skin Limited T Cell Malignancy. Soc Analytical Cytology,
Sea Island, Georgia, 1983.
* Keller, R.H., Swartz, S.J., Leven, S.
and Bar Sella, S.: Immunoregulation in Hypersensitivity
Pneumonitis: Phenotypic and Functional Studies of Bronchoalveolar
Lavage Lymphocytes. Am Acd Allergy 130:766-771, \ 1984.
* Keller, R.H., Swartz, S.J., McFadden,
P.W., Milson, T.J., Hermann, J., Thomas, E. and Patrick,
C.W.: Abnormal Peripheral Blood T Cell DNA Content in Skin
Limited T Cell Malignancy. Second International Conference
on Malignant Lymphoma, Lugano, Switzerland, June 1984.
* Patrick, C.W., Harrison, K.A, Libnoch,
J.A., Cozine, M.G. and Keller, R.H.: Monoclonal Antibody
Profiles in Human B Cell Lymphoproliferative Disorders Suggests
that B4 Positive Lymphocytes which Lack Expression of B1
Antigen May Include the B Memory Cells. Second International
Conference on Malignant Lymphoma, Lugano, Switzerland, June
1984.
* Patrick, C.W., McFadden, P.W., Buchholz,
T.B., Milson, T.J., Libnoch, J.A. and Keller, R.H.: The
Non-relevance of T4 to T8 (CD4:CD8) Ratios to Disease Activity
in B Cell Malignancies. Second International Conference
on Malignant Lymphoma, Lugano, Switzerland, June 1984.
* Keller, R.H., Swartz, S.J., Patrick,
C.W., Steven, G. and Torke, N.J.: Treatment of Naturally
Occurring Murine Non-Hodgkin's Lymphomas Using Immunoregulatory
Cell Types and IL-2. Second International Conference Malignant
Lymphoma, Lugano, Switzerland, June 1984.
* Kissebah, A.H., James, R. Krakower,
G., Arnaud, C., Etienne, J. and Keller, R.H.: Holding Media
for Cell Surface Phenotypic Analysis. Midwest Autumn Conference,
Chicago, IL, November 1984.
* Milson, T.J., Patrick, C.W., Torke,
N.J., Janicek, K.M., Harrison, K.A. and Keller, R.H.: Alterations
in Lymphoid and Myeloid Cell Surface Marker Phenotype Profiles
Associated with the Development of Basophilic Crisis in
Chronic Granulocytic Leukemia (Ph + CGL). Blood 64(5):195A,
1984
* Patrick, C.W., Libnoch, J.A., Milson,
T.J., Kortright, K.H. and Keller, R.H.: Common Variant of
B Cell Chronic Lymphocytic Leukemia is Defined by the Monoclonal
Antibody TQ1 (Leu 8). Blood 65(5):149, 1984.
* Baumann, M.A., Patrick, C.W., Libnoch,
J.A. and Keller, R.H.: Myeloid and Lymphoid Cell Surface
Phenotype in Myelodysplasia: Correlation with In Vitro Assessment
of Immune Function. Blood 64(5):186A, 1984.
* Keller, R.H., Larrick, J.W., Swartz,
S.J., Torke, N.J. and Patrick, C.W.: Treatment of a Natural
Model of Murine Non-Hodgkin's Lymphoma with Recombination
Interleukin 2(IL-2). Blood 64(5):181, 1984.
* Steven, G.C., Choi, H., Heckman, M.G.
and Keller, R.H.: Comparison of Flow Cytometry and In sit
Cell Surface Marker Analysis. Midwest Student Research Forum
XVI, Wright State University, February 1985.
* Kissebah, A.H., Krakower, G., James,
R., Aranaud, C., Etienne, J. and Keller, R.H.: Regional
Differences in Preadiopocyte Growth Potential from Immature
and Sexually Mature Female Rats. Am Fed Clin Res 33:434,
1985.
* Kissebah, A.H., Krakower, G., James,
R., Aranaud, C., Etienne, J. and Keller, R.H.: Regional
Specialization of Subcutaneous Tissue Growth Potential:
Relationship to Ovarian Function. Am Diabetes Assoc, Toronto,
Canada, November 1985.
* Baumann, M.A., Milson, T.J., Patrick,
C.W., Libnoch, J.A. and Keller, R.H.: Correlation of Natural
Killer Cell Count with Prognosis in Large Cell Lymphoma.
Blood 66:185, 1985.
* Patrick, C.W., Libnoch, J.A. and Keller,
R.H.: Clinical Utility of Dual Immunofluorescence Assay
of Monoclonal Antibodies TQ1 and (CD19) on Peripheral Blood
Cells in Chronic Lymphocytic Leukemia. Blood 66: 181, 1985.
* Patrick, C.W., Libnoch, J.A., Baumann,
M.A. and Keller, R.H.: Alterations of Myeloid Surface Receptors
recognized by the Monoclonal Antibody MY 9 (CD33) in the
Peripheral Blood May Serve to Identify Those Myelodysplastic
Patients at Increased Risk for Leukemic Conversion. Blood
66:226, 1985.
Keller, R.H., Milson, T.J., McFadden,
P.W. and Patrick, C.W.: In Vitro Augmentation of Immunologic
Responsiveness in Patients with AIDS and ARC Using Isoprinosine.
Blood 66:113, 1985.
Keller, R.H., Patrick, L.C. and Patrick,
C.W.: Isoprinosine Augments In \ Vitro Immunoglobulin Synthesis
in Chronic Lymphocytic Leukemia. Blood 66:202, 1985.
* Keller, R.H., Patrick, L.C. and Patrick,
C.W.: Isoprinosine Augments In Vitro Immunoglobulin Synthesis
in Chronic Lymphocytic Leukemia (B-CLL). International Symposium
on Recent Approaches to Chronic Lymphoproliferative Disease,
Prague, Czechoslovakia, September 1985.
* Keller, R.H., Milson, T.J. and Patrick,
C.W.: The Relationship of Larger Lymphoid Elements, Clonally
Restricted DNA Cell Cycle Analysis and Rai Staging in Chronic
Lymphocytic Leukemia (B-CLL). International Symposium on
Recent Approaches to Chronic Lymphoproliferative Disease,
Prague, Czechoslovakia, September 1985.
* Patrick, C.W., Libnoch, J.A. and Keller,
R.H.: Immunophenotypic Dissection Of Chronic Lymphocytic
Leukemia. International Symposium on Recent Approaches to
Chronic Lymphoproliferative Disease, Prague, Czechoslovakia,
September 1985.
* Keller, R.H., Libnoch, J.A., Patrick,
L.C. and Patrick, C.W.: In Vitro Improvement of Cellular
and Humoral Immune Response by Isoprinosine in B-CLL. XXI
Congress of the International Society of Haematology, Sydney,
Australia, May 1986.
* Patrick, C.W., Libnoch, J.A. and Keller,
R.H.: Prolymphocytic Leukemia of B Cells is a Distinct Biologic
Stage in B Cell Maturation. XXI Congress of The International
Society of Haematology, Sydney, Australia, May 1986.
* Patrick, C.W., Libnoch, J.A. and Keller,
R.H.: Sequential Changes in the Expression of Lymphoid Surface
Membrane Receptors in Chronic B Cell Lymphoproliferative
Disease. XXI Congress of the International Society of Haematology,
Sydney, Australia, May 1986.
* Patrick, C.W., Libnoch, J.A. and Keller,
R.H.: Clinical Utility of Dual Immunofluorescence Assay
of Monoclonal Antibodies TQ1 and B4 (CD19) on Circulating
B Cells in Chronic Lymphocytic Leukemia (B-CLL). Sixth International
Congress of Immunology, Toronto, Canada, July 1986.
* Keller, R.H., Milson, T.J., Ellingboe,
K.M. and Patrick, C.W.: Sequential Clinical, Immunoregulatory,
Phenotypic and Functional Changes in Patients with AIDS
and ARC treated with Isoprinosine. XXI Congress of the International
Society of Haematology, Sydney, Australia, May 1986.
* Keller, R.H., Milson, T.J., Ellingboe,
K.M. and Patrick, C.W.: Sequential Clinical, Immunoregulatory,
Phenotypic and Functional Changes in Patients with AIDS
and ARC treated with Isoprinosine. International Conference
on the Acquired Immunodeficiency Syndrome, Paris, France,
June 1986.
* Keller, R.H., Libnoch, J.A. and Patrick,
C.W.: T Cell Alterations in B-CLL: Sequential Changes in
CD4 and CD8 Bearing Cells and in T Cell Immunoregulation.
UCLA Symposium on Molecular and Cell Biology, Silverado,
California, December 1986.
* Patrick, C.W., Libnoch, J.A., Kallas,
G.A. and Keller, R.H.: Sequential Immunophenotypic Studies
in Chronic Lymphocytic Leukemia. UCLA Symposium on Molecular
and Cell Biology, Silverado, California, December 1986.
* Reiter, W.M., Berger, D.S., Vorce, S.,
Cimoch, P.J., Vargas, A. and Keller, R.H.: Combination Zidovudine
and Didanosine Therapy for Patients Remaining Persistently
HIV P24 Antigen-Positive Despite Zidovudine Monotherapy.
VIII International AIDS Conference, Amsterdam, Netherlands,
1992.
* Reiter, W.M., Keller, R.H., Cimoch,
P.J. and Forgione, A.: A Rapid Quantitative Flow Cytometry
Assay to Evaluate CD4 + - Lymphocyte Activation Potential
in Patients with HIV-1 Infection. VIII International AIDS
Conference, Amsterdam, Netherlands, 1992.
* Cimoch, P.J., Reiter, W.M., Vorce, D.,
Cassarella, S.K., Thompson, B. and Keller, R.H.: The Occurrence
of Cytomegalovirus (CMV) Viruria in Late- Stage HIV-1 Infection
and its Association with CMV Organ Involvement. VIII International
AIDS Conference, Amsterdam, Netherlands, 1992.
* Reiter, W.M., Beach, R.S., Vorce, D.,
Cimoch, P.J., Vargas, A., Thompson, B. and Keller, R.H.:
Longitudinal Analysis the Effect of Anti-retroviral Monotherapy
on CD4+ Lymphocyte Percentage. VIII International AIDS Conference,
Amsterdam, Netherlands, 1992.
* Keller, R.H., Van Reil, F., Maislis,
J., Lane, J.T., Reiter, W.M., Klimas, N.G. and Fletcher,
M.A.: Correlation of DR4 and DQ1 with Immunologic Defects
in the Chronic Fatigue Syndrome. First International Chronic
Fatigue Syndrome Research Conference, Albany, New York,
October 1992.
* Keller, R.H., Reiter, W.M., Lane, J.T.,
Klimas, N.G., Vargas, A. and Maislis, J.A.: Treatment of
Late-Stage AIDS Patients with Combined Monthly Anti-HIV
Hyperimmunoglobulins and Haplotype-matched Peripheral Blood
Lymphocytes. XI International Conference on AIDS, Berlin,
1993.
Reiter, W.M., Cimoch, P.J., Vorce, D.E.,
Keller, R.H., Berger, D. and Ping, A.:Eighteen Month Longitudinal
Analysis of the Effect of Zidovine MonotherapyCompared to
Combination Antiretroviral Therapy on HIV1 Disease Progression.
IX International Conference on AIDS, Berlin 1993.
* Reiter, W.M., Vorce, D.E., Cimoch, P.J.,
Keller, R.H., Berger, D.S., and Ping, A.C.: Cytotoxic CD8+
Lymphocyte Response to HIV-1 Infection Correlated with Longitudinal
Analysis of CD4+ Lymphocyte Percentage. IX International
Conference on AIDS, Berlin, 1993
Berger, D.S., Reiter, W.M., Vorce, D.E.,
Cimoch, P.J., Keller, R.H. and Ping, A.C.: Prevalence of
Red Blood Cell Magnesium Deficiency in HIV-1 Infected Patients
and its Association with Fatigue and Myalgia. IX International
Conference on AIDS, Berlin, 1993.
Reiter, W.M., Tomaka, F., Keller, R.H.,
Cimoch, P.J., Vargas, A. and Vorce, D.E.: Unrecognized Moderate
to Advanced Immunodeficiency in "HIV-Aware" Asymptomatic,
Untreated Person with HIV-1 Infection. IX International
Conference on AIDS, Berlin, 1993.
* Gomatos, P.J., Keller, R.H., Reiter,
W.M., Lane, J.T., Cimoch, P.J., Vorce, D.E., Gianetti, B.L.
and Uribe, M.R.: Haplotype-Matched Peripheral Blood Mononuclear
Cell (PBMC) Transfusions in Patients with Late-Stage AIDS.
X International Conference on AIDS, Yokohama, Japan, 1994.
* Cimoch, P.J., Loss, S.D., Houghton,
R.A., Reiter, W.M., Keller, R.H., Vorce, D.E., Nemecheck,
P.M., Berger, D.S. and Tomaka, F.L.: Antibody Response to
Pneumococcal Vaccination in HIV-1 Infected Patients. X International
Conference on AIDS, Yokohama, Japan, 1994.
* Tomaka, F.L., Cimoch, P.J., Reiter,
W.M., Keller, R.H., Berger, D.S., Piperato, J.R., Nemecheck,
P.M., Loss, S.D. and Houghton, R.A.: Prevalence of Nutritional
Deficiencies in Patients with HIV-1 Infection. X International
Conference on AIDS, Yokohama, Japan, 1994.
* Keller, R.H., Helder, L.M., Piperato,
J.P., Klimas, N.G., Reiter, W.M., Fletcher, M.A., Vorce,
D.E. and Pittibone, H.: Symptomatic Improvement Associated
with Down Regulation of Immune Hyper Reactivity by Calcium
Channel Blockade in CFIDs. American Association for Chronic
Fatigue Syndrome Research Conference, Ft Lauderdale, Florida,
1994.
* Keller, R.H., Nolan, R.P. and Patrick,
L.C.: Natural Human Interferon ( (Alpha Leukoferon) Therapy
in a Cohort of Hemophiliacs Co-infected with . HIV and Hepatitis
C. Fourth Conference on Retroviruses and Opportunistic Infections,Washington,
DC, 1997.
* Patrick, C.W. and Keller, R.H.: Patient
Screening for Myelodysplasia in Long- Term HIV+ Individuals.
Conference on Clinical Laboratory Testing in HIV, Atlanta,
GA, 1998.
* Patrick, C.W., DeLeon, M., A. Leon,
and Keller, R.H.: Measurement of glutathione (GSH) as Indicator
of Immune Status. Conference on Clinical Laboratory Testing
in HIV, Atlanta, GA 1998.
** Kushch, A. and Keller, R.H.: Neuropsychological
Correlates of Adjunct Therapy with a Nutritional/Vitamin
Supplement in a Medical Patient Sample. National Academy
of Neuropsychology, ** Orlando, FL, November 2000.
Keller, R.H.:PBS 119 Abstract "Clinical
Results of PBS 119 in Eight Patients for Two Years"
Submitted to the 12th Conference on Retroviruses & Opportunistic
Infections (CROI), 2005
Keller, R.H.: PBS 119 Abstract "In
Vitro Analysis of PBS 119 Against HIV Viral Activity in
Lab Adapted and HAART Resistant Strains of HIV" Submitted
to the 12th Conference on Retroviruses & Opportunistic
Infections (CROI), 2005
* Keller, R.H, Miller D glutathione and
DHA deficiency in HIV/AIDS : Correction with Immune Vitality
16th International AIDS congress Toronto Canada 8/2006
* Keller, R.H And Nyugen V. : PBS 119
A Novel Host - Viral Interaction inhibitor 16th International
AIDS Congress Toronto Canada 8/2006
Dr. Keller has served on the faculties of
the Mayo Graduate School of Medicine, the University of
Wisconsin and the Medical College of Wisconsin (Marquette
Univ.) He has published more than 100 original articles
in various scientific and medical journals and has been
awarded several patents. Dr Keller was elected to The Board
of Governors of the American Academy of HIV medicine, and
serves on the Scientific Advisory Board of several Biotech
companies. The Consumers’ Research Council has named
Dr. Keller one of America’s “Top Physicians
in 2003, 2004 and 2005 in the fields of Internal Medicine,
Immunology and Hematology. Dr. Keller continues his medical
practice and research activities at his clinic and laboratory
in Florida and is Chairman of the Board and Chief Scientific
Officer of Phoenix Biosciences, Inc.
|
